EIGR
Eiger BioPharmaceuticals Inc
Price:  
8.50 
USD
Volume:  
137,824.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EIGR WACC - Weighted Average Cost of Capital

The WACC of Eiger BioPharmaceuticals Inc (EIGR) is 9.0%.

The Cost of Equity of Eiger BioPharmaceuticals Inc (EIGR) is 21.65%.
The Cost of Debt of Eiger BioPharmaceuticals Inc (EIGR) is 8.15%.

Range Selected
Cost of equity 17.30% - 26.00% 21.65%
Tax rate -% - -% -%
Cost of debt 7.00% - 9.30% 8.15%
WACC 7.6% - 10.3% 9.0%
WACC

EIGR WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2.93 3.78
Additional risk adjustments 0.0% 0.5%
Cost of equity 17.30% 26.00%
Tax rate -% -%
Debt/Equity ratio 15.51 15.51
Cost of debt 7.00% 9.30%
After-tax WACC 7.6% 10.3%
Selected WACC 9.0%